에 대한 최신 뉴스 Gyre Therapeutics (NASDAQ:GYRE) 주식

Gyre Therapeutics

Gyre Therapeutics Inc is a commercial-stage pharmaceutical company developing and commercializing small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, focusing specifically on organ fibrosis. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.

Gyre Therapeutics Inc

Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.35) by 28.57 percent. This is a 36.36 percent decrease over losses of $(0.33) per share from the same period last year.

Earnings

Earnings Misses

News

BLTE

Belite Bio Q1 EPS $(0.45) Misses $(0.35) Estimate

Tvardi Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVRD#NASDAQ">TVRD</a>) reported quarterly losses of $(3.22) per share which missed the analyst consensus estimate of $(0.31) by 938.71 percent. This is a 84.09 percent increase over losses of $(20.24) per share from the same period last year. The company reported $2.57 million in sales this quarter. This is a 20.33 percent increase over sales of $2.13 million the same period last year.

TVRD

Tvardi Therapeutics Q1 EPS $(3.22) Misses $(0.31) Estimate, Sales $2.57M Up From $2.13M YoY

Reported Earlier, GreenPower Motor Announces $2M Term Loan Offering To Support Production And Working Capital

Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) reported quarterly losses of $(2.75) per share. This is a 49.45 percent increase over losses of $(5.44) per share from the same period last year.

PTIX

Protagenic Therapeutics Q1 EPS $(2.75) Up From $(5.44) YoY

Hall Of Fame Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFV#NASDAQ">HOFV</a>) reported quarterly losses of $(2.30) per share which missed the analyst consensus estimate of $(2.23) by 3.14 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.94 million which missed the analyst consensus estimate of $3.75 million by 21.47 percent. This is a 29.73 percent decrease over sales of $4.19 million the same period last year.

HOFV

Hall Of Fame Resort Q1 EPS $(2.30) Misses $(2.23) Estimate, Sales $2.94M Miss $3.75M Estimate

Korea's sixth-generation supercomputer, KISTI-6, will be 100% direct liquid-cooled to enable AI and HPC simulation for researchers across academia and industry

Reported Earlier, Hewlett Packard Enterprise Selected By KISTI To Deliver South Korea's Sixth-Generation, AI-Powered Supercomputer

Uber estimates that the net proceeds from the offering will be approximately $978.9 million (or $1,125.9 million if the initial purchaser exercises its option to purchase additional notes in full), after deducting the initial purchaser's discount and estimated offering expenses payable by Uber. Uber intends to use the net proceeds from the offering for general corporate purposes, which may include strategic investments, although Uber has not designated any specific uses at this time.

UBER

Reported Earlier, Uber Prices $1B In 0.0% Exchangeable Senior Notes Due 2028, Exchangeable Into Aurora Innovation Stock

Kezar Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZR#NASDAQ">KZR</a>) reported quarterly losses of $(2.27) per share which beat the analyst consensus estimate of $(2.61) by 13.03 percent. This is a 24.33 percent increase over losses of $(3.00) per share from the same period last year.

Earnings Beats

Kezar Life Sciences Q1 EPS $(2.27) Beats $(2.61) Estimate

Avalon Globocare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALBT#NASDAQ">ALBT</a>) reported quarterly losses of $(1.43) per share. This is a 20.56 percent increase over losses of $(1.80) per share from the same period last year. The company reported $349.80 thousand in sales this quarter. This is a 11.19 percent increase over sales of $314.59 thousand the same period last year.

ALBT

Avalon Globocare Q1 EPS $(1.43) Up From $(1.80) YoY, Sales $349.80K Up From $314.59K YoY

Pluri (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUR#NASDAQ">PLUR</a>) reported quarterly losses of $(0.94) per share. This is a 6.93 percent increase over losses of $(1.01) per share from the same period last year. The company reported $427.00 thousand in sales this quarter. This is a 501.41 percent increase over sales of $71.00 thousand the same period last year.

PLUR

Pluri Q3 EPS $(0.94) Up From $(1.01) YoY, Sales $427.00K Up From $71.00K YoY

Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) announced on Tuesday it will eliminate approximately 6,000 positions globally, representing 3% of its workforce, as the tech giant seeks to streamline operations and reduce middle management layers.
What Happened: &#8220;We continue to implement organisational changes necessary to best position the company for success in a dynamic marketplace,&#8221; Microsoft said in a statement, <a href="https://www.ft.com/content/f453e330-1e56-4b45-9889-382098025415">reported</a> the Financial Times.
The Redmond, Washington-based company joins other tech giants, including Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), in <a href="https://www.benzinga.com/25/05/45250949/tech-layoffs-get-the-headlines-but-its-uncle-sam-doge-whos-bleeding-workers-in-2025">workforce reductions while simultaneously increasing investments</a> in artificial intelligence technologies.
This latest round follows performance-related cuts affecting about 2,000 Microsoft employees earlier this year. The company previously eliminated approximately 2,500 positions from its Xbox division after acquiring Activision Blizzard, along with 1,000 roles across its HoloLens and Azure cloud computing units in the same period.
See Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45390422/trump-unveils-historic-and-transformative-600-billion-saudi-deal-predicts-markets-will-go-a-lot-higher">Trump Unveils &#8216;Historic And Transformative&#8217; $600 Billion Saudi Deal, Predicts Markets Will &#8216;Go A Lot Higher&#8217;</a>
Why It Matters: Microsoft&#8217;s CFO Amy Hood recently told investors the company was focused on &#8220;building high-performing teams and increasing our agility by reducing layers with fewer managers.&#8221; CEO Satya Nadella had earlier indicated that between 20-30% of the company&#8217;s code was <a href="https://www.benzinga.com/tech/25/04/45093643/ai-is-reshaping-coding-at-microsoft-says-nadella-30-of-code-now-ai-generated">now being written using AI tools</a>.
The layoffs come despite Microsoft&#8217;s <a href="https://www.benzinga.com/quote/MSFT/earnings">strong financial performance</a>. The company reported better-than-expected earnings for the quarter ending March and has outperformed its peers since the beginning of 2025, recently reclaiming its position as the world&#8217;s most valuable company.
The cuts affect international offices and wholly-owned subsidiaries like LinkedIn, reflecting a broader trend of workforce rebalancing across the technology sector.
Price Action: Microsoft Corp.&#8217;s stock closed at $449.14 on Tuesday, down 0.03% for the day. In after-hours trading, the stock dipped further to $448.27, a decline of 0.19%. Year to date, Microsoft&#8217;s stock has gained 7.30%. 
Microsoft is experiencing modest growth but continues to benefit from strong momentum. However, the stock scores lower on quality and valuation metrics, according to Benzinga Edge Stock Rankings. MSFT maintains a positive trend across both short- and long-term indicators. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Sign up to learn more.</a>
Photo Courtesy: Tada Images on Shutterstock.com
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45396297/cathie-wood-dumps-palantir-as-stock-touches-peak-prices-bails-on-soaring-flying-taxi-maker-archer-aviation">Cathie Wood Dumps Palantir As Stock Touches Peak Prices, Bails On Soaring Flying-Taxi Maker Archer Aviation</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Markets

AMZN

MSFT

Microsoft To Cut 6,000 Jobs Globally Amid AI-Driven Shift, Says Changes Necessary To 'Best Position The Company For Success'

Pharvaris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHVS#NASDAQ">PHVS</a>) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.82) by 8.54 percent. This is a 58.93 percent decrease over losses of $(0.56) per share from the same period last year.

PHVS

Pharvaris Q1 EPS $(0.89) Misses $(0.82) Estimate

Sonnet BioTherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SONN#NASDAQ">SONN</a>) reported quarterly losses of $(0.89) per share which missed the analyst consensus estimate of $(0.79) by 12.66 percent. This is a 258.93 percent decrease over earnings of $0.56 per share from the same period last year.

SONN

Sonnet BioTherapeutics Q2 EPS $(0.89) Misses $(0.79) Estimate

IGM Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGMS#NASDAQ">IGMS</a>) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.48) by 4.17 percent. This is a 39.76 percent increase over losses of $(0.83) per share from the same period last year. The company reported quarterly sales of $499.00 thousand which missed the analyst consensus estimate of $3.10 million by 83.91 percent. This is a 0.40 percent increase over sales of $497.00 thousand the same period last year.

IGMS

IGM Biosciences Q1 EPS $(0.50) Misses $(0.48) Estimate, Sales $499.00K Miss $3.10M Estimate

Nyxoah (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYXH#NASDAQ">NYXH</a>) reported quarterly losses of $(0.63) per share which missed the analyst consensus estimate of $(0.50) by 25.8 percent. This is a 39.78 percent decrease over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $1.10 million which missed the analyst consensus estimate of $1.64 million by 32.70 percent. This is a 16.76 percent decrease over sales of $1.33 million the same period last year.

NYXH

Nyxoah Q1 EPS $(0.63) Misses $(0.50) Estimate, Sales $1.10M Miss $1.64M Estimate

Publicly-listed holding company GD Culture Group Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDC#NASDAQ">GDC</a>) announced its intentions to raise up to $300 million to build a cryptocurrency reserve made up of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Official Trump (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>) on Monday.
What Happened: The Nasdaq-listed firm plans to use the&nbsp;proceeds from a stock sale&nbsp;to an &#8220;accredited&#8221;&nbsp;entity in the British Virgin&nbsp;Islands to finance this investment, according to a press release.
GDC said it wanted to improve its balance sheet with &#8220;high-performance, scalable digital assets,&#8221; as part of a broader pivot toward decentralized finance.
The company conducts business mainly through its wholly owned U.S. subsidiary AI Catalysis Corp. and China-based Shanghai Xianzhui Technology Co, Ltd.
GDC, which runs an e-commerce business on the Chinese-owned video-sharing app TikTok, reported no revenue last year and has a small team of just eight employees, <a href="https://www.nytimes.com/2025/05/13/us/politics/trump-crypto-purchase.html">reported </a>The New York Times, citing public filings.
See Also:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/05/45351445/xrp-skyrockets-10-what-is-going-on" target="_blank" rel="noreferrer noopener">XRP Skyrockets 10%: What Is Going On?</a>
Why It Matters: This move by GDC comes days after&nbsp;Freight Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>)&nbsp;<a href="https://www.benzinga.com/25/05/45159094/trumps-official-memecoin-adopted-as-reserve-asset-by-freight-technologies-to-advocate-for-fair-balanced-us-mexico-trade">became the first public company to adopt</a> President Donald Trump&#8217;s meme coin as a treasury reserve asset. 
The cross-border logistics company said the decision was an &#8220;effective&#8221; way to advocate for fair and free trade between Mexico and the U.S.
The meme coin has sparked political outrage, with Democratic lawmakers <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45027557/trumps-memecoin-dinner-event-sparks-impeachment-call-from-democratic-senator-says-potus-is-selling-access-to-those-who-enrich-him">accusing Trump of corruption</a> for selling access to himself in exchange for payments made with his meme coin. Trump has <a href="https://www.benzinga.com/25/05/45187462/trump-denies-personal-profit-from-memecoin-venture-i-havent-even-look">refuted claims</a> that he is financially benefiting from the coin.
Price Action: At the time of writing, TRUMP was exchanging hands at $13.56, up 7.53% in the last 24 hours, according to&nbsp;<a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Shares of GDC were up 3.27% in after-hours trading after closing 2.73% lower at $2.140 during Tuesday's regular session. The stock was up 13.23% year-to-date.
GDC scored high on the momentum metric as of this writing. If you want to fill your portfolio with similar high-momentum stocks, visit <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a> for more details.
Photo Courtesy: Bori Slim On Shutterstock.com 
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="505" height="187" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14005031/Screenshot-2025-05-14-102018.png" alt="" class="wp-image-914391" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14005031/Screenshot-2025-05-14-102018.png 505w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/14005031/Screenshot-2025-05-14-102018-300x111.png 300w" sizes="(max-width: 505px) 100vw, 505px" /></figure>
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://benzinga.com/markets/cryptocurrency/25/05/45335756/cathie-wood-stands-firm-on-bold-700000-bitcoin-prediction-for-investors-says-bull-case-in-the-1-5-million-range" target="_blank" rel="noreferrer noopener">Cathie Wood Stands Firm on Bold $700,000 Bitcoin Prediction for Investors, Says ‘Bull Case in the $1.5 Million Range&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Politics

$BTC

$TRUMP

FRGT

Trump Memecoin Adopted By China-Linked Nasdaq Company As Treasury Reserve Asset

Swiss athletic footwear company On Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) saw its stock jump 12% following stellar first-quarter of 2025 results that handily beat analyst expectations, demonstrating the strength of its premium positioning strategy.
What Happened: The former tennis player Roger Federer-backed company reported first-quarter net sales of CHF726.6 million ($865.48 million), a 43% increase year-over-year.
&#8220;Our D2C channel has again fueled our growth, increasing by 45.3% year-over-year on a reported basis and 42.4% on a constant currency basis, reaching net sales of CHF 276.9 million($330.13 million),&#8221; said CFO and Co-CEO Martin Hoffmann. &#8220;This growth ahead of our expectations has further resulted in an increased D2C share of 38.1% in the first quarter of 2025, up from 37.5% in the first quarter of 2024.&#8221;
Executive Co-Chairman Caspar Coppetti highlighted, &#8220;The strength of our direct to consumer business and its increased share resulted in an increased gross profit margin of 59.9%.&#8221; 
See Also: <a href="https://www.benzinga.com/markets/25/05/45397196/jensen-huangs-wealth-surges-37-since-liberation-day-lows-as-nvidia-re-enters-3-trillion-market-cap-club-on-saudi-chip-pact">Jensen Huang&#8217;s Wealth Surges 37% Since &#8216;Liberation Day&#8217; Lows As Nvidia Re-Enters $3 Trillion Market Cap Club On Saudi Chip Pact</a>
Why It Matters: Based on strong results, On raised its 2025 outlook, now expecting constant currency growth of at least 28%, with reported sales projected to reach at least CHF 2.8 billion ($3.34 billion). 
The company plans to raise U.S. prices starting in July to reinforce its premium brand positioning and cushion the impact of potential tariffs imposed under President Donald Trump.
Hoffmann concluded, &#8220;We are convinced that our partners and fans will continue to invest into the most premium offering in the market, setting us up for long term success from this position of strength.&#8221;
Price Action: On Holding AG&#8217;s stock closed at $57.38 on Tuesday, rising 11.83% for the day. In after-hours trading, the stock dipped slightly to $57.21, down 0.30%. Year to date, On Holding has gained 3.63%.
Photo Courtesy: Ricardo Trida On Shutterstock.com
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45397119/etoro-set-for-nasdaq-debut-crypto-and-stock-trading-platform-announces-upsized-ipo-priced-at-52-per-share">eToro Set For Nasdaq Debut, Crypto And Stock Trading Platform Announces Upsized IPO Priced At $52 Per Share</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

ONON

Roger Federer-Backed On Holding Jumps 12% As DTC Sales Soar —Sneaker Price Hikes Coming To Offset Tariffs And Fuel Premium Growth

Macro Economic Events

Econ #s

Economics

Reported Earlier, Australia Wage Price Index (QoQ) For Q1 0.9% Vs. 0.8% Est.; 0.7% Prior

Alphabet Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) YouTube will take its first snap as an NFL broadcaster on Sept. 5, streaming the Los Angeles Chargers' Week 1 opener from São Paulo free to fans worldwide on YouTube and YouTube TV. The international kickoff is the league's first exclusive live game on the platform.
What Happened: "Last year, people spent over 350 million hours watching official NFL content on YouTube," chief business officer Mary Ellen Coe said, promising creators on screen and an "interactive viewing experience."
The Friday night contest will also air on free TV in the clubs' home markets and stream on NFL+ for U.S. phones and via DAZN's NFL Game Pass abroad, mirroring past digital carve-outs.
The debut comes two seasons after YouTube TV <a href="https://www.benzinga.com/news/22/12/30155156/as-apple-said-to-bow-out-youtube-reportedly-in-advanced-talks-for-nfl-sunday-ticket">wrested</a> NFL Sunday Ticket from DirecTV. The out-of-market bundle now runs up to $378 a season. The streamer also inked a multi-year deal to carry the Super Bowl Flag Football game, deepening Google's live-sports push.
ESPN Senior NFL insider Adam Schefter noted on X that this &#8220;marks the first exclusive NFL game to be streamed live and for free in its entirety on YouTube.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">YouTube will exclusively stream the Friday night Week 1 game of the 2025 NFL season in São Paulo, Brazil on Sept. 5 to a worldwide audience on YouTube and YouTube TV. This marks the first exclusive NFL game to be streamed live and for free in its entirety on YouTube.
&mdash; Adam Schefter (@AdamSchefter) <a href="https://twitter.com/AdamSchefter/status/1922351138818461992?ref_src=twsrc%5Etfw">May 13, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See also: <a href="https://www.benzinga.com/markets/bonds/25/05/45396490/peter-schiff-says-trade-truce-aside-the-world-is-losing-confidence-in-dollar-and-in-us-ability-to-put-fiscal-house-in-order">Peter Schiff Says Trade Truce Aside, The World Is &#8216;Losing Confidence&#8217; In Dollar And In US Ability To Put &#8216;Fiscal House In Order&#8217;</a>
What To Know: Netflix's Christmas Day <a href="https://www.benzinga.com/general/sports/24/12/42728254/netflixs-nfl-push-signals-shift-in-sports-streaming-landscape-analyst-says">doubleheader last year</a> drew nearly 65 million U.S. viewers, while Peacock's 2024 Brazil matchup averaged 14.2 million domestically, <a href="https://www.adweek.com/convergent-tv/youtube-will-be-home-to-an-exclusive-nfl-game-in-2025/">according</a> to AdWeek.
Without an in-house truck, YouTube will rely on NBC Sports to produce the telecast, echoing NBC's work for Prime Video and CBS's behind-the-camera role on Netflix's holiday slate.
The Chargers' opponent will be revealed when the NFL publishes its 2025 schedule on May 14. As per a <a href="https://www.wsj.com/business/media/the-nfls-media-chief-thinks-the-league-still-has-room-to-grow-ac551f20">report</a> by WSJ, if the experiment scores, league executives hint more stand-alone windows could follow on YouTube.
Price Action: Alphabet Class A closed 0.7% up at $$159.53 on Tuesday, while the Company&#8217;s Class C shares ended the day 0.8% higher at $160.89.
Check out how Alphabet stock&#8217;s Momentum and Growth percentiles. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Click here</a> for Benzinga Edge Stock Rankings.
Photo Courtesy: Steve Jacobson On Shutterstock.com
Read next: <a href="https://www.benzinga.com/markets/25/05/45397196/jensen-huangs-wealth-surges-37-since-liberation-day-lows-as-nvidia-re-enters-3-trillion-market-cap-club-on-saudi-chip-pact">Jensen Huang&#8217;s Wealth Surges 37% Since &#8216;Liberation Day&#8217; Lows As Nvidia Re-Enters $3 Trillion Market Cap Club On Saudi Chip Pact</a>

Tech

GOOG

GOOGL

YouTube Scores NFL First: Chargers Game In Brazil To Stream Free Worldwide

Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) broke through $2,700 in a searing rally Tuesday, bolstered by improving macroeconomic conditions.
What happened: The second-largest cryptocurrency by capitalization soared over 8% in the last 24 hours, reaching levels last seen in the last week of February.
ETH's trading volume jumped 10.30% to nearly $35 billion, indicating high liquidity and trader interest.
The upsurge made ETH the biggest large-cap cryptocurrency gainer over the last 24 hours, significantly outpacing Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>).
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/25/05/45339966/bitcoin-creator-satoshi-nakamotos-estimated-wealth-crosses-bill-gates-amid-apex-cryptos-sharp-rebound">Bill Gates Left Behind By Satoshi Nakamoto: Bitcoin Creator&#8217;s Wealth Now Eclipses That Of Microsoft Co-Founder Amid Crypto&#8217;s Sharp Rebound</a>
The rally also excited ETH's derivatives traders, as the Open Interest skyrocketed 16% to $32.28 billion in the last 24 hours, <a href="https://www.coinglass.com/BitcoinOpenInterest">according </a>to Coinglass, the highest since Jan. 24.
Nearly $160 million in bearish leveraged bets on ETH were erased, accounting for 64% of total short liquidations during the last 24 hours. Over 60% of all Binance traders with open ETH positions were long as of this writing.
Institutional investors started piling on the cryptocurrency. London-based digital asset investment firm Abraxas Capital purchased another $84.7 million in ETH, taking its total buys in the last week to $561 million, according to Lookonchain.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Just as we suspected, Abraxas Capital borrowed <a href="https://twitter.com/search?q=%24USDT&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$USDT</a> to buy more <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a>. When we posted, <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a> was at $2,460, now it has broken above $2,700—up ~10%! Over the past week, Abraxas Capital has bought 242,652 <a href="https://twitter.com/search?q=%24ETH&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$ETH</a>($561M).<a href="https://t.co/vZTxLPcuJS">https://t.co/vZTxLPcuJS</a><a href="https://t.co/qZZkGndZEd">https://t.co/qZZkGndZEd</a> <a href="https://t.co/o7NgUjSguU">pic.twitter.com/o7NgUjSguU</a>
&mdash; Lookonchain (@lookonchain) <a href="https://twitter.com/lookonchain/status/1922465465554682131?ref_src=twsrc%5Etfw">May 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The uptick followed <a href="https://www.benzinga.com/25/05/45396450/bitcoin-ethereum-dogecoin-pop-on-softer-inflation-analyst-says-cocktail-for-bitcoins-ballistic-rise-was-in-the-works">softer-than-expected consumer inflation</a> data for April, easing fears about President Donald Trump&#8217;s trade policies and encouraging a risk-on mood.
Price Action:&nbsp; At the time of writing, ETH was exchanging hands at $2,638.49, up 8.63% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. The coin was still 13% away from reclaiming $3,000.
Photo Courtesy: VPLAB On Shutterstock.com
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45339772/michael-saylor-harnesses-ai-to-drive-home-an-important-message-on-bitcoin-its-going-up-forever">Michael Saylor Harnesses AI To Drive Home An Important Message On Bitcoin: &#8216;It&#8217;s Going Up Forever&#8217;</a></li>
</ul>

Movers

Trading Ideas

$ETH

$XRP

Ethereum Spikes Nearly 9% Over 24 Hours: Is $3000 Next?

Events

Press Releases

Sidoti Events, LLC's Virtual August Micro-Cap Conference

Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference

Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference

Health Care

Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis

Gyre Therapeutics Reports Third Quarter 2024 and Year-To-Date Financial Results and Provides Business Update

Management

Gyre Therapeutics Announces the Appointment of Ping Zhang to Board of Directors

Gyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Gyre Therapeutics Announces Publication of Protocol for Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis in Journal of Clinical and Translational Hepatology

Comments

Gyre Therapeutics

뉴스

에 대한 최신 뉴스 Gyre Therapeutics (NASDAQ:GYRE) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌